# Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery

Study · id `cardio:ct-nct01431222` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01431222](<https://clinicaltrials.gov/study/NCT01431222>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01431222

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01431222. Randomized; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2013-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01431222, source copy `cardio:ctgov-nct01431222-2011-09-09`, retrieved 2026-10-26)
- Start date: 2011-09 (registry gives no type) (ClinicalTrials.gov record NCT01431222, source copy `cardio:ctgov-nct01431222-2011-09-09`, retrieved 2026-10-26)
- Primary completion: 2013-09 (anticipated) (ClinicalTrials.gov record NCT01431222, source copy `cardio:ctgov-nct01431222-2011-09-09`, retrieved 2026-10-26)
- Completion: 2014-09 (anticipated) (ClinicalTrials.gov record NCT01431222, source copy `cardio:ctgov-nct01431222-2011-09-09`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT01431222, source copy `cardio:ctgov-nct01431222-2011-09-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01431222-2011-09-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery
- Acronym: ISAR-CLIP
- Condition: Mitral Regurgitation
- Intervention (Device): percutaneous treatment by implanting a Mitra Clip device
- Lead sponsor: Deutsches Herzzentrum Muenchen
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Deutsches Herzzentrum Muenchen (`cardio:org-deutsches-herzzentrum-muenchen`)

## Provenance

Content hash: 41b1db4517d93b205a3721d1e111d44644fc3e4e28ba147ae733e4b7683f3661
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
